About us
Research
Latest news
Press releases
Investors
Q&A
Contact

About us
Research
Latest news
Press releases
Investors
Q&A
Contact

Rights Issue 2019

Prospectus

Prospectus for Scandion Oncology

Scandion Oncology Investor Relations

Nils Brünner, CEO
E: nb@scandiononcology.com
T: +45 26144708

Investor information

Spotlight
Waterfront Building
Klarabergsviadukten 63, 9 tr
101 23 Stockholm
Sweden

Phone: +46 8 511 68 000
Website: www.spotlightstockmarket.com

Qualified Adviser

Sedermera Fondkommission
Norra Vallgatan 64
211 22 Malmö
Sweden

Phone: + 46 406151410
Website: www.sedermera.se

Scandion Oncology A/S

Symbion
Fruebjergvej 3
DK 2100 København
Denmark

Social media

Linkedin
Twitter

Press

Nils Brünner, CEO
E: nb@scandiononcology.com
T: +45 26144708

Stay updated with our newsletter

Get notified on mail, when news or press release is posted on our website.

Email Address *

Name

Co-funded by the Horizon 2020 programme of the European Union

Co-funded by the COSME programme of the European Union

Privacy and Cookie Policy